Truist Financial Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Announces Target Price $62
Cantor Fitzgerald Raises Price Target on Bristol-Myers Squibb to $50 From $45
Cantor Fitzgerald Reiterates Overweight on AbbVie, Maintains $200 Price Target
Argus Research Maintains United Parcel Service(UPS.US) With Hold Rating
Goldman Sachs Adjusts Price Target on Chevron to $177 From $175
A Quick Look at Today's Ratings for AbbVie(ABBV.US), With a Forecast Between $200 to $214
Morgan Stanley Adjusts AbbVie Price Target to $211 From $196
AbbVie Analyst Ratings
J.P. Morgan Maintains Philip Morris International(PM.US) With Buy Rating, Raises Target Price to $125
HSBC Adjusts Price Target on International Business Machines to $162 From $148, Maintains Reduce Rating
Buy Rating Affirmed for AbbVie Amidst Strong Financials and Strategic Management
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
Evercore Maintains IBM Corp(IBM.US) With Buy Rating, Maintains Target Price $215
Piper Sandler Adjusts Price Target on AbbVie to $196 From $190
Philip Morris Price Target Raised to $125.00/Share From $110.00 by JP Morgan
IBM Price Target Raised to $205.00/Share From $190.00 by Stifel
IBM Analyst Ratings
BMO Capital Maintains IBM Corp(IBM.US) With Hold Rating, Raises Target Price to $210
Morgan Stanley Maintains United Parcel Service(UPS.US) With Sell Rating, Maintains Target Price $100
Morgan Stanley Sticks to Their Hold Rating for International Business Machines (IBM)